Last Updated on December 31, 2023 by The Health Master
Download the notification: The National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices of twenty eight (28) formulations under the Drugs (Prices Control) Order, 2013, based on the decision of the Authority meeting held on based on the decision of 94th Authority Meeting dated 23.12.2021 vide notification S.O. 5423(E) dated 28-12-2021.
NPPA, in its order on December, 28, listed the twenty eight (28) formulations for which it has fixed retail prices. A list of the formulations has been given below:
Formulations:
| Sl. No. | Name of the Formulation / Brand Name | Strength | Unit | Manufacturer & Marketing Company | Retail Price (Rs.) |
| (1) | (2) | (3) | (4) | (5) | (6) |
| 1. | Cyclosporine Ophthalmic Solution | Each ml contains: Cyclosporine IP 0.9mg Aqueous Buffered Vehicle q.s. | Each 0.25ml Pack | M/s Sun Pharmaceutical Industries Limited | 51.29 |
| 2. | Amoxicillin + Potassium Clavulanate Oral Suspension IP | Each 5ml of reconstituted suspension contains: Amoxicillin Trihydrate eq. to Amoxicillin IP 600mg Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 42.9mg | 1 ML | M/s Alkem Healthscience / M/s Alkem Laboratories Ltd. | 3.36 |
| 3. | Povidone- Iodine + Ornidazole Ointment | Composition: Povidone-Iodine IP 5%w/w (Available Iodine 0.5%w/w) Ornidazole IP 1% w/w In an Ointment base | 1 gm | M/s Innova Captab Ltd. / M/s Emcure Pharmaceuticals Ltd. | 3.78 |
| 4. | Povidone Iodine Topical Solution | Each 100ml solution contains: Povidone Iodine IP 1.0g (Available Iodine 0.1 g) 2-Propanol IP 50g | Each Pack (500ml) | M/s GS Pharmabutor Pvt. Ltd. / M/s Win Medicare Pvt. Ltd. | 230.00 |
| 5. | Atorvastatin + Clopidogrel Capsule | Each hard gelatin capsule Contains: Atorvastatin Calcium IP eq to Atorvastatin 40mg (As green coloured spherical pellets) Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablets Each containing 37.5mg Clopidogrel Tablets IP) | 1 Capsule | M/s Windlas Biotech Limited / M/s Intas Pharmaceuticals Ltd. | 28.08 |
| 6. | Diclofenac Diethylamine + Methyl Salicylate + Menthol Gel | Gel contains: Diclofenac Diethylamine IP 2.32% w/w (equivalent to Diclofenac Sodium IP 2.0% w/w) Methyl Salicylate IP 10% w/w Menthol IP 5% w/w | 1 gm | M/s Tuton Pharmaceuticals /M/s Unison Pharmaceuticals Pvt. Ltd. | 3.69 |
| 7. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Sun Pharma Laboratories Limited | 9.86 |
| 8. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Sun Pharma Laboratories Limited | 10.81 |
| 9. | Atorvastatin + Clopidogrel + Aspirin Capsule | Each hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As coloured pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablet each containing 37.5mg clopidogrel tablet IP), Aspirin IP 75mg (As enteric coated white coloured pellets) | 1 Capsule | M/s Windlas Biotech Limited / M/s Torrent Pharmaceuticals Limited | 12.92 |
| 10. | Atorvastatin + Clopidogrel + Aspirin Capsule | Each hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As coloured pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two reddish brown coloured film coated tablet each containing 37.5mg clopidogrel tablet IP), Aspirin IP 75mg (As enteric coated white coloured pellets) | 1 Capsule | M/s Windlas Biotech Pvt. Ltd. / M/s USV Pvt. Ltd. | 12.92 |
| 11. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Lupin Limited | 9.86 |
| 12. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 6.25mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Lupin Limited | 10.81 |
| 13. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 47.50mg eq. to Metoprolol Tartrate (as extended release) 50mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Lupin Limited | 11.92 |
| 14. | Telmisartan, Chlorthalidone & Metoprolol (ER) Tablet | Each film coated bilayered tablet contains: Telmisartan IP 40mg, Chlorthalidone IP 12.50mg Metoprolol Succinate IP 23.75mg eq. to Metoprolol Tartrate (as extended release) 25mg | 1 Tablet | M/s Ravenbhel Healthcare Pvt. Ltd. /M/s Lupin Limited | 10.88 |
| 15. | Diclofenac injection IP | Each ml contains: Diclofenac Sodium IP 75mg Water for injection IP | 1 ml | M/s Nitin Lifesciences Ltd./ M/s Modi- Mundipharma Pvt. Ltd. | 20.27 |
| 16. | Amoxycillin + Potassium Clavulanate Oral Suspension IP | Each 5ml of the reconstituted suspension contains: Amoxycillin Trihydrate eq. to Amoxycillin IP 400mg Potassium Clavulanate Diluted IP eq. to Clovulanic Acid 57mg | 1 ml | M/s Associated Biotech./ M/s Eris Healthcare Pvt. Limited | 3.68 |
| 17. | Mefenamic Acid+ Tranexamic Acid Tablet | Each film coated tablet contains: Mefenamic Acid IP 250mg Tranexamic Acid IP 500mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Eris Healthcare Pvt. Limited | 26.12 |
| 18. | Atorvastatin + Clopidogrel Capsule | Each hard gelatine capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As green coloured spherical pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablets Each containing 37.5mg Clopidogrel Tablets IP), | 1 Capsule | M/s Windlas Biotech Limited / M/s Torrent Pharmaceuticals Limited | 28.08 |
| 19. | Glimepiride + Metformin Hydrochloride + (Sustained Release) + Voglibose Tablet | Each uncoated bilayer tablet contains : Glimepiride IP – 1 mg Metformin Hydrochloride IP – 500 mg (Sustained Release Form) Voglibose IP – 0.2 mg | 1 Tablet | M/s Theon Pharmaceuticals Limited / M/s FDC Limited | 9.82 |
| 20. | Metoprolol Succinate prolonged Released Tablets IP | Each film coated prolonged release tablet contains: Metoprolol Succinate IP 95mg eq. to Metoprolol Tartrate 100mg | 1 Tablet | M/s Micro Labs Limited | 11.38 |
| 21. | Glimepiride + Metformin Hydrochloride + (Sustained Release) + Voglibose Tablet | Each uncoated bilayer tablet contains : Glimepiride IP – 2 mg Metformin Hydrochloride IP – 500 mg (Sustained Release Form) Voglibose IP – 0.2 mg | 1 Tablet | M/s Theon Pharmaceuticals Limited / M/s FDC Limited | 12.50 |
| 22. | Clobazam Mouth Dissolving tablet | Each uncoated Mouth Dissolving tablet contains: Clobazam IP 2.5mg | 1 Tablet | M/s Pure & Cure Healthcare Pvt. Ltd. / M/s Intas Pharmaceuticals Limited | 2.54 |
| 23. | Acetylcysteine + Acebrophylline Tablet | Each film coated tablet contains: Acetylcysteine BP 600mg Acebrophylline 100mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/ Cipla limited | 12.48 |
| 24. | Levetiracetam Tablet IP | Each film coated tablet contains: Levetiracetam IP 1000mg | 1 Tablet | M/s Pure and Cure Healthcare Pvt. Ltd. / M/s Mankind Pharma Ltd. | 29.87 |
| 25. | Levetiracetam Tablet IP | Each film coated tablet contains: Levetiracetam IP 1000mg | 1 Tablet | M/s Swiss Garnier Genexiaa Sciences Pvt. Ltd. / M/s Wockhardt Limited | 26.70 |
| 26. | Glycopyrronium + Formoterol Fumarate + Budesonide Powder for Inhalation | Each capsule contains: Glycopyrrolate IP eq. to Glycopyrronium 25mcg Formoterol Fumarate Dihydrate IP eq. to Formoterol Fumarate 12mcg Budesonide IP 400mcg | 1 Capsule | M/s Zydus Healthcare Limited | 12.64 |
| 27. | Esomeprazole + Domperidone SR Capsule | Each hard Gelatin Capsule Contains: Esomeprazole Magnesium Trihydrate IP eq. to Esomeprazole 40mg (as gastro-resistant pellets) Domperidone IP 30mg (as sustained release pellets) | 1 Capsule | M/s Indu Drugs Private Limited | 10.70 |
| 28. | Atorvastatin + Clopidogrel Capsule | Each hard gelatin capsule contains: Atorvastatin Calcium IP eq. to Atorvastatin 40mg (As green coloured spherical pellets), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As two brown coloured film coated tablets Each containing 37.5mg Clopidogrel Tablets IP), | 1 Capsule | M/s Windlas Biotech Limited / M/s Zydus Healthcare Ltd. | 30.74 |
(a) The manufacturer of above mentioned formulations i.e. “new drug” under paragraph 2(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
Latest notifications – DPCO /NPPA
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
NPPA fixes retail price of 20 formulations: December 2021
NPPA fixes retail price of 2 formulations: November 2021
NPPA fixes retail price of 47 formulations: November 2021
NPPA fixes retail price of 12 Anti Diabetic medicines: October 2021
NPPA fixes retail price of 23 formulations: September 2021
NPPA fixes retail price of 1 formulation: September 2021
NPPA extends price cap on liquid Medical Oxygen and Oxygen inhalation
CDSCO approves Corbevax, Covovax and Molnupiravir for restricted use
Nutraceutical sector concerned over FSSAI’s notification on Marketers
We must learn to live with Covid: WHO
Govt extends implementation date of UDI for Medical Devices
DCGI gives nod to Sun Pharma arm for Molnupiravir in India
USFDA gives nod to Granules India for Prazosin HCL capsules
E-pharmacies, Telemedicine to help cut health expenses
Won’t allow drug peddlers to ruin lives of youth: HM
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
(c ) The manufacturers may add goods and services tax only if they have paid actually or if it is payable to the Government on the ceiling price mentioned in column (5) of the above said table.
(d) The ceiling price for a pack of the scheduled formulation shall be arrived at by the concerned manufacturer in accordance with the ceiling price specified in column (5) of the above table as per provisions contained in paragraph 11 of the Drugs (Prices Control) Order, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(e) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(F) Where an existing manufacturer of scheduled formulation with dosage or strength or both as specified in the above table launches a new drug as per paragraph 2 (u) of the DPCO, 2013 such existing manufacturer shall apply for prior price approval of such new drug to the NPPA in Form I as specified under Schedule-II of the DPCO, 2013.
(g) The manufacturers of above said scheduled formulations shall furnish quarterly return to the NPPA, in respect of production / import and sale of scheduled formulations in Form-III of Schedule-II of the DPCO, 2013 through IPDMS. Any manufacturer intending to discontinue production of above said scheduled formulation shall furnish information to the NPPA, in respect of discontinuation of production and / or import of scheduled formulation in Form-IV of Schedule-II of the DPCO, 2013 at least six months prior to the intended date of discontinuation.
(h) The manufacturers not complying with the ceiling price and notes specified hereinabove shall be liable to deposit the overcharged amount along with interest thereon under the provisions of the Drugs (Prices Control) Order, 2013 read with Essential Commodities Act, 1955.
(i) Consequent to the issue of ceiling price of such formulation as specified in column (2) of the above table in this notification, the price order(s) fixing ceiling or retail price, if any, issued prior to the above said date of notification, stand(s) superseded.
Latest notifications – DPCO /NPPA
FAQs – On DPCO: Drugs (Prices Control) Order, 2013
NPPA fixes retail price of 47 formulations: November 2021
NPPA fixes retail price of 12 Anti Diabetic medicines: October 2021
NPPA fixes retail price of 23 formulations: September 2021
NPPA fixes retail price of 1 formulation: September 2021
NPPA extends ceiling price regulation on Orthopaedic knee implants
NPPA extends price cap on LMO and Oxygen inhalation
Procedure to obtain license for Commercial Testing Laboratories
Govt asks States to collaborate with proposed Medical Devices Parks
Morepen gets USFDA nod for anti-allergy drug
Roche develops new research Test Kits for Omicron variant
Booster dose of these 6 Vaccines safe, increases immunity: Study
DGFT notifies norms for Sodium Salicylate & Methylcobalamin
NPPA to hire 33 professionals for various levels of its operations
Govt to amend Drug Rules for list of colours permitted to…
NPPA fixes retail price of 47 formulations: November 2021
Latest Notifications regarding Pharmaceuticals
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
